MBI
CRL icon

Montrusco Bolton Investments’s Charles River Laboratories CRL Stock Holding History

Montrusco Bolton Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-489,751
Closed -$133M – 59
2024
Q1 		$133M Sell
489,751
-232,340
-32% -$55.5M 1.41% 23
2023
Q4 		$167M Sell
722,091
-133,296
-16% -$26.2M 2.08% 20
2023
Q3 		$164M Buy
855,387
+225,562
+36% +$46.3M 2.39% 20
2023
Q2 		$131M Buy
629,825
+219,637
+54% +$43.7M 2.02% 22
2023
Q1 		$80.4M Sell
410,188
-33,658
-8% -$7.63M 1.66% 29
2022
Q4 		$94M Buy
443,846
+110,107
+33% +$24M 2.18% 20
2022
Q3 		$64.7M Buy
333,739
+31,078
+10% +$6.71M 1.71% 27
2022
Q2 		$63.9M Sell
302,661
-947
-0.3% -$231K 1.7% 28
2022
Q1 		$85.3M Buy
303,608
+136,231
+81% +$42M 1.97% 26
2021
Q4 		$62.1M Buy
167,377
+26,294
+19% +$10.2M 1.46% 30
2021
Q3 		$57.4M Sell
141,083
-89,487
-39% -$37.2M 1.56% 26
2021
Q2 		$84M Sell
230,570
-57,279
-20% -$19.1M 2.52% 15
2021
Q1 		$82.1M Buy
287,849
+50,486
+21% +$14M 2.68% 12
2020
Q4 		$57.8M Buy
+237,363
New +$56.5M 2.54% 12

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Montrusco Bolton Investments's CRL Position: Q2 2024 in Review

Montrusco Bolton Investments sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 489,751 shares — an estimated $133M sold.

Montrusco Bolton Investments first reported a position in CRL in Q4 2020 and held it in 14 quarters. The position peaked at $167M in Q4 2023. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • Montrusco Bolton Investments reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • Montrusco Bolton Investments sold 489,751 Charles River Laboratories shares in Q2 2024, an estimated $133M.
  • Montrusco Bolton Investments first reported a position in Charles River Laboratories in Q4 2020 and held it in 14 quarters.
  • Montrusco Bolton Investments's Charles River Laboratories position peaked at $167M in Q4 2023.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on Montrusco Bolton Investments's 13F filing for Q2 2024, filed 24 Jul 2024.